OHARA, T., B. K. MENON, F. S. AL-AJLAN, M. HORN, M. NAJM, A. AL-SULTAN, J. PUIG, D. DOWLATSHAHI, A. I. C. SANZ, SI SOHN, S. H. AHN, A. Y. POPPE, Robert MIKULÍK, N. ASDAGHI, T. S. FIELD, A. JIN, T. ASIL, J. M. BOULANGER, F. LETTERI, S. DEY, J. W. EVANS, M. GOYAL, M. D. HILL, M. ALMEKHLAFI a A. M. DEMCHUK. Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment The INTERRSeCT Study. Stroke. Dallas: Lippincott Williams & Wilkins, 2021, roč. 52, č. 1, s. 203-212. ISSN 0039-2499. Dostupné z: https://dx.doi.org/10.1161/STROKEAHA.120.029292.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment The INTERRSeCT Study
Autoři OHARA, T., B. K. MENON, F. S. AL-AJLAN, M. HORN, M. NAJM, A. AL-SULTAN, J. PUIG, D. DOWLATSHAHI, A. I. C. SANZ, SI SOHN, S. H. AHN, A. Y. POPPE, Robert MIKULÍK (203 Česká republika, domácí), N. ASDAGHI, T. S. FIELD, A. JIN, T. ASIL, J. M. BOULANGER, F. LETTERI, S. DEY, J. W. EVANS, M. GOYAL, M. D. HILL, M. ALMEKHLAFI a A. M. DEMCHUK (garant).
Vydání Stroke, Dallas, Lippincott Williams & Wilkins, 2021, 0039-2499.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30210 Clinical neurology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 10.170
Kód RIV RIV/00216224:14110/21:00121123
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1161/STROKEAHA.120.029292
UT WoS 000603081900056
Klíčová slova anglicky angiography; computed tomography angiography; internal carotid artery; middle cerebral artery; reperfusion
Štítky 14110127, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 11. 2. 2021 14:20.
Anotace
Background and Purpose: There is interest in what happens over time to the thrombus after intravenous alteplase. We study the effect of alteplase on thrombus structure and its impact on clinical outcome in patients with acute stroke. Methods: Intravenous alteplase treated stroke patients with intracranial internal carotid artery or middle cerebral artery occlusion identified on baseline computed tomography angiography and with follow-up vascular imaging (computed tomography angiography or first run of angiography before endovascular therapy) were enrolled from INTERRSeCT study (Identifying New Approaches to Optimize Thrombus Characterization for Predicting Early Recanalization and Reperfusion With IV Alteplase and Other Treatments Using Serial CT Angiography). Thrombus movement after intravenous alteplase was classified into complete recanalization, thrombus migration, thrombus fragmentation, and no change. Thrombus migration was diagnosed when occlusion site moved distally and graded according to degrees of thrombus movement (grade 0-3). Thrombus fragmentation was diagnosed when a new distal occlusion in addition to the primary occlusion was identified on follow-up imaging. The association between thrombus movement and clinical outcome was also evaluated. Results: Among 427 patients in this study, thrombus movement was seen in 54% with a median time of 123 minutes from alteplase administration to follow-up imaging, and sub-classified as marked (thrombus migration grade 2-3 + complete recanalization; 27%) and mild to moderate thrombus movement (thrombus fragmentation + thrombus migration grade 0-1; 27%). In patients with proximal M1/internal carotid artery occlusion, marked thrombus movement was associated with a higher rate of good outcome (90-day modified Rankin Scale, 0-2) compared with mild to moderate movement (52% versus 27%; adjusted odds ratio, 5.64 [95% CI, 1.72-20.10]). No difference was seen in outcomes between mild to moderate thrombus movement and no change. In M1 distal/M2 occlusion, marked thrombus movement was associated with improved 90-day good outcome compared with no change (70% versus 56%; adjusted odds ratio, 2.54 [95% CI, 1.21-5.51]). Conclusions: Early thrombus movement is common after intravenous alteplase. Marked thrombus migration leads to good clinical outcomes. Thrombus dynamics over time should be further evaluated in clinical trials of acute reperfusion therapy.
VytisknoutZobrazeno: 25. 4. 2024 03:16